Respiratory / Generic (single ingredient)         

  Duasma HFA MDI contains corticosteroid Budesonide as active ingredient. Marketing approval for Taiwan and Hong Kong was granted in 2013 and 2015 respectively. It is under the process of reviewing for international submission. With a market size of over US800million globally, it is currently the only inhaled corticosteroid drugs available for pregnant use, principally against asthma disease.